Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Centessa Pharmaceuticals PlcADS | 19,963,157 | 19,963,157 | 0 | $262.32M | $484.11M | 65.03% | +$221.79M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 7,464,572 | 7,464,572 | 0 | $71.59M | $87.86M | 11.80% | +$16.27M |
| Newamsterdam Pharma Company ORDINARY SHARES | 2,869,565 | 2,869,565 | 0 | $51.97M | $81.61M | 10.96% | +$29.64M |
| Rapt Therapeutics Inc | 0 | 2,794,000 | +2,794,000 | $0 | $72.06M | 9.68% | +$72.06M |
| Aura Biosciences, Inc.(AURA) | 3,039,892 | 3,039,892 | 0 | $19.03M | $18.79M | 2.52% | -$243.2K |
| Rapt Therapeutics Inc | 2,794,000 | 0 | -2,794,000 | $22.35M | $0 | — | -$22.35M |